# Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

> **NCT00979706** · PHASE4 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 22 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** HAART
- **DRUG:** HAART + Immunotherapy

## Key facts

- **NCT ID:** NCT00979706
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979706, "Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00979706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*